Induction of apoptosis by cancer chemotherapy

Experimental Cell Research

Volumn 256, Issue 1, 2000, Pages 42-49

  Kaufmann, Scott H ^a   Earnshaw, William C ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; ASPARAGINASE; BLEOMYCIN; CAMPTOTHECIN; CELL SURFACE RECEPTOR; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOHEXIMIDE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOCHROME C OXIDASE; DEMECOLCINE; DIPHTHERIA TOXIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; FAS LIGAND; FLOXURIDINE; FLUDARABINE; GEMCITABINE; HORMONE ANTAGONIST; HYDROXYUREA; INTERCALATING AGENT; METHOTREXATE; MITOXANTRONE; PACLITAXEL; PROTEIN SYNTHESIS INHIBITOR; PUROMYCIN; TOPOTECAN; UNINDEXED DRUG;

ANIMAL CELL; APOPTOSIS; CANCER CHEMOTHERAPY; CROSS RESISTANCE; DNA DEGRADATION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034630167     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4838     Document Type: Article

References (50)

1. Arends M. J., Wyllie A. H. Apoptosis: Mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:1991;223-254.
2. Mesner P., Budihardjo I., Kaufmann S. H. Chemotherapy-induced apoptosis. Adv. Pharmacol. 41:1997;461-499.
3. Li X., Gong J., Feldman E., Seiter K., Traganos F., Darzynkiewicz Z. Apoptotic cell death during treatment of leukemias. Leuk. Lymph. 13:1994;65-70.
4. Kaufmann S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 49:1989;5870-5878.
5. Houghton J. A. Apoptosis and drug response. Curr. Opin. Oncol. 11:1999;475-481.
6. Earnshaw W. C., Martins L. M., Kaufmann S. H. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:1999;383-424.
7. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-actived DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
8. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D. R., Aebersold R., Siderovski D. P., Penninger J. M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
9. Liu X., Li P., Widlak P., Zou H., Luo X., Garrard W. T., Wang X. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA. 95:1998;8461-8466.
10. Samejima K., Toné S., Kottke T., Enari M., Sakahira H., Cooke C. A., Durrieu F., Martins L. M., Nagata S., Kaufmann S. H., Earnshaw W. C. Transition from caspase-dependant to caspase-independant mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:1998;225-239.
11. Sahara S., Aoto M., Eguchi Y., Imamoto N., Yoneda Y., Tsujimoto Y. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature. 401:1999;168-173.
12. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
13. Ashkenazi A., Dixit V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:1999;255-260.
14. Siegel R. M., Martin D. A., Zheng L., Ng S. Y., Bertin J., Cohen J., Lenardo M. J. Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis. J. Cell Biol. 141:1998;1243-1253.
15. Medema J. P., Scaffidi C., Kischkel F. C., Shevchenko A., Mann M., Krammer P. H., Peter M. E. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:1997;2794-2804.
16. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., Martinou J. C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome C release during apoptosis. J. Cell Biol. 144:1999;891-901.
17. Griffiths G. J., Dubrez L., Morgan C. P., Jones N. A., Whitehouse J., Corfe B. M., Dive C., Hickman J. A. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144:1999;903-914.
18. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
19. Stennicke H. R., Deveraux Q. L., Humke E. W., Reed J. C., Dixit V. M., Salvesen G. S. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:1999;8359-8362.
20. Rodriguez J., Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13:1999;3179-3184.
21. Deveraux Q. L., Reed J. C. IAP family proteins - Suppressors of apoptosis. Genes Dev. 13:1999;239-252.
22. Khwaja A. Akt is more than just a bad kinase. Nature. 401:1999;33-34.
23. Jiang Y., Woronicz J. D., Liu W., Goeddel D. V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 283:1999;543-546.
24. Gross A., McDonnell J. M., Korsmeyer S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
25. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
26. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
27. Kennedy S. G., Kandel E. S., Cross T. K., Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome C from mitochondria. Mol. Cell. Biol. 19:1999;5800-5810.
28. Downward J. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8:1998;49-54.
29. Scaffidi C., Fulda S., Srivinivasan A., Friesen C., Li F., Tomaselli K. J., Debatin K. M., Krammer P. H., Peter M. E. Two CD95 (APO-1)/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
30. Slee E. A., Harte M. T., Kluck R. M., Wolf B. B., Casiano C. A., Newmeyer D. D., Wang H.-G., Reed J. C., Nicholson D. W., Alnemri E. S., Green D. R., Martin S. J. Ordering the cytochrome C-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:1999;281-292.
31. Friesen C., Herr I., Krammer P. H., Debatin K.-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2:1996;574-577.
32. Friesen C., Fulda S., Debatin K. M. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia. 11:1997;1833-1841.
33. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., Green D. R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell. 1:1998;543-551.
34. Müller M., Strand S., Hug H., Heinemann E.-M., Walczak H., Hofmann W. J., Stremmel W., Krammer P. H., Galle P. R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1-Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99:1997;403-413.
35. Fulda S., Sieverts H., Friesen C., Herr I., Debatin K. M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57:1997;3823-3829.
36. Fulda S., Scaffidi C., Pietsch T., Krammer P. H., Peter M. E., Debatin K.-M. Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells. Cell Death Diff. 5:1998;884-893.
37. Fulda S., Los M., Friesen C., Debatin K. M. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Int. J. Cancer. 76:1998;105-114.
38. Villunger A., Egle A., Kos M., Hartmann B. L., Geley S., Kofler R., Greil R. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res. 57:1997;3331-3334.
39. McGahon A. J., Costa P. A., Daly L., Cotter T. G. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. Brit. J. Haematol. 101:1998;539-547.
40. Adjei A. A., Charron M., Rowinsky E. K., Svingen P. A., Miller J., Reid J. C., Sebolt-Leopold J., Ames M. M., Kaufmann S. H. Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II: Prevention of cleavable complex formation. Clin. Cancer Res. 4:1998;683-691.
41. Eischen C. M., Kottke T. J., Martins L. M., Basi G. S., Tung J. S., Earnshaw W. C., Leibson P. J., Kaufmann S. H. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90:1997;935-943.
42. Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.-T. Fas ligand-independent, FADD-mediated action of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274:1999;7987-7992.
43. Wesselborg S., Engels I. H., Rossmann E., Los M., Schulze-Osthoff K. Anticancer drugs induce caspase-8-FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood. 93:1999;3053-3063.
44. Glaser T., Wagenknecht B., Groscurth P., Krammer P. H., Weller M. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in malignant glioma cells. Oncogene. 18:1999;5044-5053.
45. Shain K. H., Landowski T. H., Buyuksal I., Cantor A. B., Dalton W. S. Clonal variability in CD95-expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 myeloma cell line. Leukemia. 2000.
46. Kataoka T., Schroter M., Hahne M., Schneider P., Irmler M., Thome M., Froelich C. J., Tschopp J. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J. Immunol. 161:1998;3936-3942.
47. Svingen P. A., Tefferi A., Kottke T. J., Kaur G., Narayanan V. L., Sausville E. A., Kaufmann S. H. Effects of the Bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. Clin. Cancer Res. 6:2000;237-249.
48. Sun X. M., MacFarlane M., Zhuang J., Wolf B. B., Green D. R., Cohen G. M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:1999;5053-5060.
49. Houghton J. A., Harwood F. G., Tillman D. M. Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc. Natl. Acad. Sci. USA. 94:1997;8144-8149.
50. Tillman D. M., Petak I., Houghton J. A. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clin. Cancer Res. 5:1999;425-430.